Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank77
5Y CAGR-10.1%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
-10.1%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.77M-20.4%
2024$8.51M+1695.8%
2023$474000.00+106.3%
2022$-7.51M-172.6%
2021$10.35M-10.3%
2020$11.54M+104.2%
2019$5.65M+425.4%
2018$1.08M+661.7%
2017$141204.00+1137.0%
2016$-13617.00-